Integra LifeSciences to Present At the Thomas Weisel Partners Healthcare and Morgan Stanley Global Healthcare Unplugged Conferences in September
PLAINSBORO, N.J., Aug 28, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it will present at two Conferences.
On Wednesday, September 9, 2009 at 2:05 PM, Gerry Carlozzi, Integra's Executive Vice President and Chief Operating Officer, will present at the Thomas Weisel Partners Healthcare Conference to be held at the Four Seasons Hotel in Boston, MA.
On Tuesday, September 15, 2009 at 9:45 AM, Stuart Essig, Integra's President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference to be held at the Grand Hyatt Hotel in New York City. There will be no webcast for these two conferences.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Our products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit www.Integra-LS.com.
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2008 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
IART-G
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Integra LifeSciences Holdings Corp.
CONTACT: Integra LifeSciences Holdings Corporation John B. Henneman, III, Executive Vice President, Finance and Administration and Chief Financial Officer (609) 275-0500 jhenneman@Integra-LS.com Investor Relations Angela Steinway (609) 936-2268 angela.steinway@integra-LS.com
(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.
News Provided by COMTEX